Lee CC; kesselheim - Search Results

Year	Number of Results
2018	1
2020	5
2021	8
2022	0

1

Public-sector Contributions to Novel Biologic Drugs.

Nayak RK, Lee CC, Avorn J, Kesselheim AS. Nayak RK, et al. Among authors: lee cc. JAMA Intern Med. 2021 Nov 1;181(11):1522-1525. doi: 10.1001/jamainternmed.2021.3720. JAMA Intern Med. 2021. PMID: 34279545

2

Cost to Medicare of Delayed Adalimumab Biosimilar Availability.

Lee CC, Najafzadeh M, Kesselheim AS, Sarpatwari A. Lee CC, et al. Clin Pharmacol Ther. 2021 Oct;110(4):1050-1056. doi: 10.1002/cpt.2322. Epub 2021 Jul 6. Clin Pharmacol Ther. 2021. PMID: 34145566

3

Variations in Generic Combination Opioid Use Across State Medicaid Programs.

Lee CC, Kesselheim AS, Avorn J. Lee CC, et al. J Gen Intern Med. 2021 Oct;36(10):3240-3242. doi: 10.1007/s11606-020-06315-x. Epub 2020 Nov 2. J Gen Intern Med. 2021. PMID: 33140274 No abstract available.

4

Origins and Ownership of Remdesivir: Implications for Pricing.

Lee CC, Darrow JJ, Avorn J, Kesselheim AS. Lee CC, et al. J Law Med Ethics. 2020 Sep;48(3):613-618. doi: 10.1177/1073110520958890. J Law Med Ethics. 2020. PMID: 33021169 No abstract available.

5

Clinical Development Times for Biosimilars in the United States.

Lee CC, Kesselheim AS, Sarpatwari A. Lee CC, et al. Mayo Clin Proc. 2020 Oct;95(10):2152-2154. doi: 10.1016/j.mayocp.2020.06.039. Mayo Clin Proc. 2020. PMID: 33012346

6

An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.

Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, Moneer O, Avorn J. Kesselheim AS, et al. Among authors: lee cc. Health Aff (Millwood). 2021 Jan;40(1):25-32. doi: 10.1377/hlthaff.2020.01620. Epub 2020 Nov 19. Health Aff (Millwood). 2021. PMID: 33211535

7

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020.

Moneer O, Lee CC, Avorn J, Kesselheim AS. Moneer O, et al. Among authors: lee cc. JAMA Netw Open. 2021 Apr 1;4(4):e218530. doi: 10.1001/jamanetworkopen.2021.8530. JAMA Netw Open. 2021. PMID: 33929526 Free PMC article.

8

Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017.

Rome BN, Lee CC, Gagne JJ, Kesselheim AS. Rome BN, et al. Among authors: lee cc. Value Health. 2021 Jun;24(6):804-811. doi: 10.1016/j.jval.2020.12.020. Epub 2021 Apr 22. Value Health. 2021. PMID: 34119078

9

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018.

Rome BN, Lee CC, Kesselheim AS. Rome BN, et al. Among authors: lee cc. Clin Pharmacol Ther. 2021 Feb;109(2):367-371. doi: 10.1002/cpt.1983. Epub 2020 Aug 7. Clin Pharmacol Ther. 2021. PMID: 32654122

10

Medicare Spending on Brand-name Combination Medications vs Their Generic Constituents.

Sacks CA, Lee CC, Kesselheim AS, Avorn J. Sacks CA, et al. Among authors: lee cc. JAMA. 2018 Aug 21;320(7):650-656. doi: 10.1001/jama.2018.11439. JAMA. 2018. PMID: 30140875 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results